Absci (ABSI) EBT (2020 - 2026)
Absci (ABSI) posted EBT of -$29.6 million for Q1 2026, little changed sequentially from -$29.7 million in Q4 2025, and down 12.26% YoY from -$33.7 million in Q1 2025.
Absci (ABSI) EBT (2020 - 2026) Analysis & Trends
Absci has reported EBT for 7 years, with the latest figure at -$29.6 million in Q1 2026.
- Quarterly EBT fell 12.26% year-over-year to -$29.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$118.3 million (down 10.17% YoY) and the FY2025 annual result came in at -$115.1 million, down 11.72% from the prior year.
- EBT was little changed at -$29.6 million in Q1 2026 per ABSI's latest filing, from -$29.7 million in the prior quarter.
- Over five years, EBT peaked at -$20.0 million in Q4 2022 and troughed at -$41.7 million in Q2 2023.
- A 5-year average of -$27.3 million and a median of -$27.6 million in 2022 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2024: EBT sank 152.41% in 2022, then soared 40.59% in 2024.
- Over 5 years, EBT stood at -$20.0 million in 2022, then dropped by 17.66% to -$23.5 million in 2023, then retreated by 23.26% to -$29.0 million in 2024, then slipped by 2.63% to -$29.7 million in 2025, then increased by 0.48% to -$29.6 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$29.6 million, -$29.7 million, and -$28.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | -33.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.17 Mn |
| Mar 31, 2026 | -29.58 Mn |
| Dec 31, 2025 | -29.72 Mn |
| Sep 30, 2025 | -28.60 Mn |
| Jun 30, 2025 | -30.44 Mn |
| Mar 31, 2025 | -26.35 Mn |
| Dec 31, 2024 | -28.96 Mn |
| Sep 30, 2024 | -27.36 Mn |
| Jun 30, 2024 | -24.75 Mn |
| Mar 31, 2024 | -21.96 Mn |
| Dec 31, 2023 | -23.50 Mn |
| Sep 30, 2023 | -21.96 Mn |
| Jun 30, 2023 | -41.66 Mn |
| Mar 31, 2023 | -23.35 Mn |
| Dec 31, 2022 | -19.97 Mn |
| Sep 30, 2022 | -27.57 Mn |
| Jun 30, 2022 | -28.95 Mn |
| Mar 31, 2022 | -28.87 Mn |
| Dec 31, 2021 | -26.27 Mn |
| Sep 30, 2021 | -25.34 Mn |